Fund Holdings — BML Capital Management, LLC

Total Portfolio Value:
$108.70M
Total Bought:
$10.20M
Total Sold:
$26.89M
Net Transaction:
-$16.69M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Aclaris Therapeutics, Inc.(ACRS)14,250,00014,250,0000$20.23M$27.07M24.91%+$6.84M
Atea Pharmaceuticals, Inc.(AVIR)7,609,8127,473,963-135,849$27.40M$21.67M19.94%-$5.72M
Adverum Biotechnologies Inc3,057,5263,057,5260$6.57M$13.85M12.74%+$7.28M
Instil Bio, Inc.(TIL)534,899645,600+110,701$11.14M$11.53M10.61%+$388.5K
Oramed Pharmaceuticals Inc.(ORMP)3,083,2533,167,231+83,978$6.94M$8.36M7.69%+$1.42M
PMV Pharmaceuticals, Inc.(PMVP)5,000,0005,292,000+292,000$5.30M$7.41M6.82%+$2.11M
Alumis Inc1,210,4151,210,4150$3.63M$4.83M4.44%+$1.20M
Lava Therapeutics NvSHS1,970,6101,970,6100$2.60M$3.07M2.83%+$472.9K
Kezar Life Sciences Inc
COM NEW
635,183720,787+85,604$2.91M$2.81M2.59%-$98.1K
Connect Biopharma Holdings LimitedSHS(CNTB)01,267,500+1,267,500$0$1.91M1.76%+$1.91M
ImageneBio, Inc.(IMA)0182,509+182,509$0$1.49M1.37%+$1.49M
LeonaBio, Inc.(LONA)0323,066+323,066$0$1.34M1.23%+$1.34M
Astrotech Corp220,410220,4100$1.27M$1.08M0.99%-$192.9K
Target Corporation(TGT)010,000+10,000$0$897.0K0.83%+$897.0K
Vistagen Therapeutics, Inc.(VTGN)150,000150,0000$300.0K$532.5K0.49%+$232.5K
Arvinas, Inc.(ARVN)050,000+50,000$0$426.0K0.39%+$426.0K
Lisata Therapeutics, Inc.(LSTA)209,814109,841-99,973$608.3K$287.8K0.26%-$320.5K
Mural Oncology Pub Ltd Co057,500+57,500$0$119.0K0.11%+$119.0K
Third Harmonic Bio Inc3,824,4173,824,4170$20.77M$0—-$20.77M
Athira Pharma Inc3,230,6670-3,230,667$975.7K$0—-$975.7K
Connect Biopharma Hldgs LtdADS1,821,5580-1,821,558$1.79M$0—-$1.79M
Corvus Pharmaceuticals, Inc.(CRVS)118,7660-118,766$475.1K$0—-$475.1K
Elevation Oncology Inc5,890,4340-5,890,434$2.16M$0—-$2.16M
Essa Pharma Inc4,221,5460-4,221,546$7.18M$0—-$7.18M
Hillevax Inc91,9130-91,913$182.9K$0—-$182.9K
Ikena Oncology Inc4,030,1020-4,030,102$5.40M$0—-$5.40M
Milestone Pharmaceuticals Inc.(MIST)1,136,0910-1,136,091$2.20M$0—-$2.20M
Turnstone Biologics Corp1,103,3860-1,103,386$396.1K$0—-$396.1K
Verrica Pharmaceuticals Inc.(VRCA)174,6510-174,651$92.6K$0—-$92.6K
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q3 2025 | TickerTrail